[Federal Register: November 8, 2006 (Volume 71, Number 216)]
[Notices]
[Page 65544]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08no06-110]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on August 21, 2006 and August
24, 2006, Johnson Matthey, Inc., Custom Pharmaceuticals Department,
2003 Nolte Drive, West Deptford, New Jersey 08066, made application by
letter to the Drug Enforcement Administration (DEA) to be registered as
a bulk manufacturer of the basic classes of controlled substances
listed in schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Nabilone (7379)............................ II
Noroxymorphone (9668)...................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for sales to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration pursuant to 21 CFR
1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative/ODL; or any being sent via express mail should be sent
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must
be filed no later than January 8, 2007.
Dated: November 2, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-18844 Filed 11-7-06; 8:45 am]
BILLING CODE 4410-09-P